March 06, 2024


Professor Eyad Elkord was a Professor of Immunology with the Department of Applied Biology, College of Science, University of Sharjah, United Arab Emirates and holds an Honorary Professor position with University of Salford, UK. He was a Postdoctoral Scientist (Jan 2005 - Dec 2007) at the Paterson Institute for Cancer Research, University of Manchester (UK) and was promoted to a Research Fellow/Group Leader of the Clinical Immunotherapy Laboratory at the University of Manchester (Jan 2008 - Nov 2010). He then undertook a Lecturer position with the University of Salford and was promoted in August 2012 to a Senior Lecturer position. He moved to the College of Medicine & Health Science, United Arab Emirates University, in 2012 and was an Associate Professor of Immunology until September 2016. He then worked as a Principal Investigator at Qatar Biomedical Research Institute and a Professor at Hamad Bin Khalifa University, Qatar.

Professor Elkord is a member of several highly regarded scientific societies and an editorial board member for peer-reviewed international journals such as Frontiers in Immunology & Oncology (specialty Cancer Immunity & Immunotherapy), BMC Cancer, Vaccines, Heliyon and Journal of Immunology Research. He is a reviewer to many international journals and well-known funding agents, such as the UK Medical Research Council, European Research Council, Dutch Research Council. Dr Elkord has 130 publications in peer-reviewed high-impact international journals with more than 11000 citations and an h-index of 47 and M-index of 2.7. In recognition of his research influence, Dr Elkord has been named in Stanford University’s yearly and career global lists of the top 2% of scientists for four consecutive years (2019-2022), achieving the position in the top 0.26% in the Immunology subfield.

Teaching / Research field

At XJTLU, Professor Elkord will teach Immunology, Biology/Molecular Biology for undergraduate students.

His main research interest focuses on Oncoimmunology, which is an important and hot topic. He is interested in studying the tumor microenvironment and investigating mechanisms utilized by tumor cells to evade immune-mediated destruction with special focus on the role and function of immunosuppressive cells [T regulatory cells (Tregs) and myeloid-derived suppressor cells (MDSCs)]. Professor Elkord’s research on immune regulation mechanisms, especially the role and function of T regulatory cells in cancer, is internationally recognized. And for the wider applications of his research,the Identification of biomarkers which could improve patients’ response to different modalities of immunotherapy, leading to improving quality of life for patients.


“XJTLU is a fast-growing international university with great potentials. I am happy to be part of and contribute to this bright future. I am also keen to establish a productive and an internationally recognized research group at XJTLU. ”

March 06, 2024